BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 10, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» GI-108, an IL-2-based bifunctional agent that restores cytotoxic activity of immunosuppressed immune cells in TME
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
GI-108, an IL-2-based bifunctional agent that restores cytotoxic activity of immunosuppressed immune cells in TME
Nov. 7, 2023
Researchers from GI Innovation Inc. have developed GI-108, a novel bispecific fusion protein designed to augment antitumor immunity.
BioWorld Science
Conferences
Society for Immunotherapy of Cancer
Cancer
Immuno-oncology
